Le Lézard
Classified in: Health
Subjects: PDT, MAT

Ace Valley Celebrates Sex Positivity with Debut of Lust and Thrust Cannabis Infused Gummies


Lust Cherry Rose and Thrust Watermelon Goji aim to make good sex greater

SMITHS FALLS, ON, Oct. 21, 2022 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis and cannabinoid-based consumer product company, today announced an extension of its Ace Valley brand portfolio with the launch of Lust Cherry Rose and Thrust Watermelon Goji. These two new, distinctly-flavoured, gummies are the first of their kind in the Canadian market, celebrating the intersection of cannabis and sex positivity by empowering consumers to enhance their personal experiences.

In an online survey1, 75 percent of participants said they use cannabis to enhance sex, and 42 percent of participants said they already use cannabis to connect with their partner. The flavours of Lust and Thrust aim to enhance both solo and partnered play via delicious bite-sized gummies and aspire to make good sex greater.

"Ace Valley celebrates sex positivity, including those who are already combining cannabis and sex, as well as those who are curious about it," said Tara Rozalowsky, Vice President, Brand Marketing. "Lust and Thrust gummies were created with pleasure in mind, and both products are a natural extension of Ace Valley's innovative portfolio, which elevates experiences and empowers consumers to use cannabis their way, on their terms."

Earlier this year, Ace Valley introduced the first-ever CBN gummies in Canada with Blackberry Lemon Dream, designed with your nighttime routine in mind. The introduction of Lust and Thrust further amplifies the brand's commitment to purposeful consumption and empowering the pleasures of the plant.

Ace Valley Lust and Thrust gummies are available for purchase via legal recreational cannabis e-commerce channels and retail locations in select regions. For more information, please visit AceValley.com.

1 Online survey, Strainprint: Cannabis & Sex (not a clinical trial) conducted on Feb 13-28 2020. Results from 1,383 anonymous survey responses. Everyone experiences cannabis differently.

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information, visit www.canopygrowth.com.

SOURCE Canopy Growth Corporation


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: